Granules India Ltd
NSE:GRANULES
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
370.1
718.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GRANULES stock under the Base Case scenario is 517.35 INR. Compared to the current market price of 559.5 INR, Granules India Ltd is Overvalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Granules India Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GRANULES cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Granules India Ltd
Balance Sheet Decomposition
Granules India Ltd
Current Assets | 29.1B |
Cash & Short-Term Investments | 1B |
Receivables | 11.3B |
Other Current Assets | 16.7B |
Non-Current Assets | 26.2B |
Long-Term Investments | 215.2m |
PP&E | 21.2B |
Intangibles | 2.5B |
Other Non-Current Assets | 2.3B |
Current Liabilities | 20.8B |
Accounts Payable | 7.5B |
Accrued Liabilities | 706.1m |
Short-Term Debt | 10.5B |
Other Current Liabilities | 2.1B |
Non-Current Liabilities | 2.1B |
Long-Term Debt | 1.5B |
Other Non-Current Liabilities | 609.8m |
Earnings Waterfall
Granules India Ltd
Revenue
|
47B
INR
|
Cost of Revenue
|
-20.3B
INR
|
Gross Profit
|
26.7B
INR
|
Operating Expenses
|
-19.1B
INR
|
Operating Income
|
7.7B
INR
|
Other Expenses
|
-2.8B
INR
|
Net Income
|
4.9B
INR
|
Free Cash Flow Analysis
Granules India Ltd
INR | |
Free Cash Flow | INR |
GRANULES Profitability Score
Profitability Due Diligence
Granules India Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Granules India Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
GRANULES Solvency Score
Solvency Due Diligence
Granules India Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Granules India Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GRANULES Price Targets Summary
Granules India Ltd
According to Wall Street analysts, the average 1-year price target for GRANULES is 636.23 INR with a low forecast of 520.15 INR and a high forecast of 735 INR.
Dividends
Current shareholder yield for GRANULES is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
GRANULES Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 3,686 full-time employees. The firm operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The firm has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The company has over seven manufacturing facilities, approximately six of which are located in India and one in the United States. The firm sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
Contact
IPO
Employees
Officers
The intrinsic value of one GRANULES stock under the Base Case scenario is 517.35 INR.
Compared to the current market price of 559.5 INR, Granules India Ltd is Overvalued by 8%.